Casdin Capital β 2022 Investments
6 investments dated 2022 Β· listed companies and verified rows first Β· show all
Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.
BiotechDeep TechHealthtechLeiden, NL
Koenraad Wiedhaup(Founder & Chief Executive Officer)inRonald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)inDinko Valerio(Founder and Chair of the Supervisory Board)inJintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)in
Co-investorsClavystBioF-Prime CapitalGV (Google Ventures)Bluebird VenturesEuropean Innovation Council FundEuropean Investment Bank+5 more
A drug discovery company staffed by scientists and industry specialists focused on developing pharmaceutical candidates.
Biotech
Timur Yusufzai(Founder)inAsit Parikh(Chief Executive Officer)in
Co-investorsNextech InvestThird Rock VenturesAlexandriaCreacion VenturesGoldman SachsInvus+3 more
ONI develops the Nanoimager, an automated super-resolution imaging system.
BiotechDeep TechHardwareMedical DevicesOxford, GB
Co-investorsARCH Venture PartnersArtis VenturesFuture Planet CapitalOxford Technology ManagementVertical Venture PartnersAxon Ventures+5 more
Ventus discovers and develops small-molecule medicines using its proprietary ReSOLVE platform, focused on structure-based drug discovery.
AI & Machine LearningBiotechDeep TechHealthtechWaltham, US
Judith Lieberman(Co-Founder)Daniel Koerwer(Executive Officer)inMichael Crackower(Executive Officer)inZachary McNealy(Executive Officer)Marcelo Bigal, M.D., Ph.D.(President and Chief Executive Officer)
BoardJosh Resnick(Director)in
Co-investorsAndreessen HorowitzGV (Google Ventures)RA CapitalSoftBank Vision FundVersant VenturesBiotechnology Value Fund+2 more
BiotechSan Francisco, US
Kaz Ohno(Executive Officer)James Lim(Executive Officer)Brian S. Feth(Executive Officer, Director)
BoardSaeid Akhtari(Director)
Co-investorsDynamk CapitalFormic VenturesViking Global Investors
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Standard BioTools
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.